The specific inhibition of HepG2 cells proliferation by apoptosis induced by gabexate mesilate

International Journal of Clinical and Experimental Pathology

Volumn 3, Issue 7, 2010, Pages 710-717

  Ozeki, Tsuneo ^a   Natori, Tsuneo ^b  

^a Ozeki Internal Medicine Clinic   (Japan)

^b SRL INC   (Japan)

Author keywords

Apoptosis; Gabexate mesilate; Hepatocellular carcinoma; HepG2cell

Indexed keywords

GABEXATE; SERINE PROTEINASE INHIBITOR;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN HEPG2; DRUG EFFECT; HUMAN; IMMUNOHISTOCHEMISTRY; NICK END LABELING;

APOPTOSIS; CELL PROLIFERATION; GABEXATE; HEP G2 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; SERINE PROTEINASE INHIBITORS;

EID: 77956036241     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ikeda.K, Saito.S, Koida.I, Arase.Y, Tsubota.A, Chagama.K, Kumada.H, Kawanishi.M. A multivariate analysis of risk factors for hepatocellular carcinogeneres : a prospective observation of 795 patients with viral and aleoholic cirrhosis. Hepatology. 1993 : 18:47-53.
2. Bruix.J, Liovet JM, Castells, Montana.X, Bru.C, A yuso MDC , Vllana.R, Rods. J. Transarterial cmbolization versus gymptomatic treatment in patients with advanced hepatocellular carcinoma: result of a yandomiged controlled trial in a single institusion. Hepatology 1995;27:1578-1583.
3. Matsui.O, Kadoya.M, Yoshikawa.J, Gobata.T, Arai.K, Demachi.H, Miyayama.S, Takashima.T, Unoura.M, Kogayashi.K. Small hepatocellular carcinoma: Treatment with subsegmental transcatheter Asterial embolization. Radiology 1998; 188:79-83.
4. Takahashi. Y, Nishioka.K. Survival without tumor shrimkage : Re-evaluation of Survival gain by cytostatic effect of chemotherapy.I Natl Cancer Institute. 1995: 262-1263.
5. Ando.E, Tanaka.M, Yamashita.F, Kuromatsu.R, Yutani.S, Fukumori.K, Sumie.S, Yano.Y Okuda.K, Sata.M. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis : analysis of 48 cases. Cancer.2002 :95 :588-595.
6. Ishikawa.T, Ichida.T, Sugitani.S, Tsuboi.Y, Genda.T, Sugahara.S Uehara.K, Inayoshi.J, Yokoyama. J Ishimoto.Y, Askakura.H, Improved survival with oral administration of enteric -coated tagefur/uracil for advanced stage IV-A hepatocellular carcinoma, J Gastroenterol Hepatol 2001:16 :452-459.
7. Ikeda.M, Maeda.S, Shibata.J, Muta.R, Ashihara. H, Tanaka.M, Fujiyama.S. Tomita.K. Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma. Omecogy .2004:65:24-31.
8. Murakawa M, Okamura T, Shibuya T, Harada M, Otsuka T and Niho Y. Use of a synthetic protease inhibitor for the treatment of L-asparaginaseinduced acute pancreatitis complicated by disseminated intravascular coagulation. Ann Hematol 1992; 64: 249-252.
9. Nkano S, Mugikura M, Endoh M, Ogami Y and Otsuki M. Acute pancreatitis with diabetic ketoacidosis associated with hypermyoglobinemia, acute renal failure, and DIC. J Gastroenterol 1996; 31: 623-626.
10. Sakurai M, Abe H, Okamura N, Inoue Y, Akiyoshi T, Matsuyama K, Uchida T and Otsuka M. Stability of gabexate mesilate products: Influence of the addition of mannitol. Biomed Mater Eng 2010; 20: 13-20.
11. Kusunoki N, Ito T, Sakurai N, Suguro T, Handa H and Kawai S. A novel celecoxib derivative potently induces apoptosis of human synovial fibroblasts. J Pharmacol Exp Ther 2005; 314: 796-803.
12. Oie S, Ono M, Fukushima H, Hosoi F, Yano H, Maruyama Y, Kojiro M, Terada T, Hirano K, Kuwano M and Yamada Y. Alteration of dihydropyrimidine dehydrogenase expression by IFNalpha affects the antiproliferative effects of 5-fluororuracil in human hepatocellular carcinoma cells. Mol Cancer Ther 2007; 6: 2310-2318.
13. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR and Sikorska M. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. Embo J 1993; 12: 3679-3684.
14. Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC, Wu TT, Huang S and Xie K. Drastic downregulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 2005; 65: 2746-2754.
15. Funaki N, Sasano H, Shizawa S, Nio M, Iwami D, Ohi R and Nagura H. Apoptosis and cell proliferation in biliary atresia. J Pathol 1998; 186: 429-433.
16. Wijsman JH, Jonker RR, Keijzer R, van de Velde CJ, Cornelisse CJ and van Dierendonck JH. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 1993; 41: 7-12.
17. Gavrieli Y, Sherman Y and Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
18. Kerr JF, Wyllie AH and Currie AR. Apoptosis: a basic biological phenomenon with wide-rangin implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
19. Lakhani SA, Masud A, Kuida K, Porter GA, Jr., Booth CJ, Mehal WZ, Inayat I and Flavell RA. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 2006; 311: 847-851.
20. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P and Moll um. P53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003; 11: 577-590.
21. Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 2003; 195: 158-167.
22. Martin-Renedo J, Mauriz JL, Jorquera F, Ruiz-Andres O, Gonzalez P and Gonzalez-Gallego J. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res 2008; 45: 532-540.